Skip to content

Hip Infiltration in Hip Arthroplasty (HiHa) study – a randomized controlled trial

Status
Not yet recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-509109-57-01
Acronym
OC-2023-005
Enrollment
120
Registered
2025-04-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Total Hip Arthroplasty / THA

Brief summary

Use of escape pain medication during the first 6 hours after the intra-articular injection of the hip

Detailed description

Percentage of patients that use escape pain medication on day 0 and during hospital stay until discharge, Pain measured with NRS, Side effects related to the use of pain medication, Amount of other escape medication used, Satisfaction measured with the Net Promotor Score (NPS), Perioperative blood loss, Need for blood tranfusion

Interventions

DRUGSODIUM CHLORIDE

Sponsors

Reinier Haga Groep Orthopedisch Centrum B.V.
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
Use of escape pain medication during the first 6 hours after the intra-articular injection of the hip

Secondary

MeasureTime frame
Percentage of patients that use escape pain medication on day 0 and during hospital stay until discharge, Pain measured with NRS, Side effects related to the use of pain medication, Amount of other escape medication used, Satisfaction measured with the Net Promotor Score (NPS), Perioperative blood loss, Need for blood tranfusion

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026